āĻšā§āĻŽINO âĸ NASDAQ
add
Inovio Pharmaceuticals Inc
ā§§.ā§Ģā§§$
āĻāĻŖā§āĻāĻž āĻĒāĻ°ā§:(ā§Ļ.ā§Šā§Ŧ%)+ā§Ļ.ā§Ļā§Ļā§Ģā§Ē
ā§§.ā§Ģā§¨$
āĻŦāĻ¨ā§āĻ§ āĻāĻā§: ā§¨ā§§ āĻāĻžāĻ¨ā§, ā§Ŧ:ā§Ļā§§:ā§Ēā§¯ PM GMT -ā§Ģ · USD · NASDAQ · āĻĄāĻŋāĻ¸āĻā§āĻ˛ā§āĻŽāĻžāĻ°
āĻ¸ā§āĻāĻāĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ āĻ¯ā§āĻā§āĻ¤āĻ°āĻžāĻˇā§āĻā§āĻ°-āĻ āĻ¤āĻžāĻ˛āĻŋāĻāĻžāĻā§āĻā§āĻ¤ āĻ¸āĻŋāĻāĻŋāĻāĻ°āĻŋāĻāĻŋ
āĻāĻžāĻ˛ āĻļā§āĻˇ āĻ¯ā§ āĻĻāĻžāĻŽā§ āĻāĻŋāĻ˛
ā§§.ā§Ģā§§$
āĻ¸āĻžāĻ°āĻž āĻĻāĻŋāĻ¨ā§āĻ° āĻā§āĻ°ā§āĻĄāĻŋāĻā§ā§ āĻ¸ā§āĻāĻā§āĻ° āĻĻāĻžāĻŽā§āĻ° āĻāĻ āĻž āĻ¨āĻžāĻŽāĻžāĻ° āĻ°ā§āĻā§āĻ
ā§§.ā§Ēā§¯$ - ā§§.ā§Ģā§Ē$
āĻ¸āĻžāĻ°āĻž āĻŦāĻāĻ°ā§āĻ° āĻ°ā§āĻā§āĻ
ā§§.ā§Šā§Ļ$ - ā§¨.ā§¯ā§Ž$
āĻŽāĻžāĻ°ā§āĻā§āĻ āĻā§āĻ¯āĻžāĻĒ
ā§§ā§Ļ.ā§Šā§Â āĻā§ USD
āĻāĻĄāĻŧ āĻāĻ˛āĻŋāĻāĻŽ
ā§§ā§¯.ā§Ļā§Ģ āĻ˛āĻž
P/E āĻ
āĻ¨ā§āĻĒāĻžāĻ¤
-
āĻ˛āĻā§āĻ¯āĻžāĻāĻļ āĻĒā§āĻ°āĻĻāĻžāĻ¨
-
āĻĒā§āĻ°āĻžāĻāĻŽāĻžāĻ°āĻŋ āĻāĻā§āĻ¸āĻā§āĻā§āĻ
NASDAQ
āĻŦāĻžāĻāĻžāĻ° āĻ¸āĻāĻŦāĻžāĻĻ
āĻĢāĻžāĻāĻ¨āĻžāĻ¨ā§āĻ¸āĻŋā§āĻžāĻ˛ āĻĒāĻžāĻ°āĻĢāĻ°ā§āĻŽā§āĻ¯āĻžāĻ¨ā§āĻ¸
āĻā§ā§āĻ° āĻ¸ā§āĻā§āĻāĻŽā§āĻ¨ā§āĻ
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ
| (USD) | āĻ¸ā§āĻĒ ā§¨ā§Ļā§¨ā§Ģinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | â | â |
āĻŦā§āĻ¯āĻŦāĻ¸āĻž āĻāĻžāĻ˛āĻžāĻ¨ā§āĻ° āĻāĻ°āĻ | ā§ā§Ž.ā§ā§Â āĻ˛āĻž | -ā§Ž.ā§Ģā§Ģ% |
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | -ā§Ē.ā§Ģā§Ģ āĻā§ | -ā§Žā§Ļ.ā§ā§¯% |
āĻ¨ā§āĻ āĻĒā§āĻ°āĻĢāĻŋāĻ āĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ | â | â |
āĻļā§ā§āĻžāĻ° āĻĒā§āĻ°āĻ¤āĻŋ āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | -ā§Ļ.ā§Žā§ | ā§¨.ā§¨ā§Ģ% |
EBITDA | -ā§¨.ā§Ļā§¯Â āĻā§ | ā§¨ā§¨.ā§Ģā§Š% |
āĻĒā§āĻ°āĻ¯ā§āĻā§āĻ¯ āĻā§āĻ¯āĻžāĻā§āĻ¸ā§āĻ° āĻšāĻžāĻ° | â | â |
āĻŦā§āĻ¯āĻžāĻ˛ā§āĻ¨ā§āĻ¸ āĻļāĻŋāĻ
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
| (USD) | āĻ¸ā§āĻĒ ā§¨ā§Ļā§¨ā§Ģinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻā§āĻ¯āĻžāĻļ āĻ āĻāĻŽ āĻ¸āĻŽā§ā§āĻ° āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ | ā§Ģ.ā§Ļā§ŽÂ āĻā§ | -ā§Ēā§Ļ.ā§Ļā§¯% |
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ | ā§Ŧ.ā§¯ā§Ē āĻā§ | -ā§Šā§Ģ.ā§§ā§¯% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§.ā§ā§§Â āĻā§ | ā§§ā§Šā§Ļ.ā§Ļā§Š% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | -ā§ā§.ā§¨ā§Ļ āĻ˛āĻž | â |
āĻāĻāĻāĻ¸ā§āĻā§āĻ¯āĻžāĻ¨ā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāĻ° | ā§Ģ.ā§Šā§Ŧ āĻā§ | â |
āĻĒā§āĻ°āĻžāĻāĻ¸ āĻā§ āĻŦā§āĻ āĻ°ā§āĻļāĻŋāĻ | -ā§§ā§Ļ.ā§ā§¯ | â |
āĻ¸āĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | -ā§ā§.ā§Ļā§Ŧ% | â |
āĻŽā§āĻ˛āĻ§āĻ¨ āĻĨā§āĻā§ āĻā§ | -ā§¨ā§Ģā§Ģ.ā§Ŧā§§% | â |
āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨
| (USD) | āĻ¸ā§āĻĒ ā§¨ā§Ļā§¨ā§Ģinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | -ā§Ē.ā§Ģā§Ģ āĻā§ | -ā§Žā§Ļ.ā§ā§¯% |
āĻ
āĻĒāĻžāĻ°ā§āĻļāĻ¨ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āĻ¯āĻžāĻļ | -ā§¨.ā§§ā§Ŧ āĻā§ | ā§¨ā§§.ā§Šā§¯% |
āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | ā§Žā§Ž.ā§Ŧā§Â āĻ˛āĻž | -ā§Šā§.ā§Ļā§§% |
āĻĢāĻžāĻāĻ¨ā§āĻ¯āĻžāĻ¨ā§āĻ¸āĻŋāĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | ā§¨.ā§Ēā§¯Â āĻā§ | ā§Š,ā§Ŧā§ā§¨.ā§Ēā§Ļ% |
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ | ā§§.ā§¨ā§¨Â āĻā§ | ā§§ā§¯ā§Ŧ.ā§§ā§Ģ% |
āĻĢā§āĻ°āĻŋ āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§ | ā§¨.ā§ā§Ļ āĻā§ | ā§¨ā§Ģā§Ē.ā§Šā§¯% |
āĻ¸āĻŽā§āĻĒāĻ°ā§āĻā§
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
āĻ¸āĻŋāĻāĻ
āĻ¸ā§āĻĨāĻžāĻĒāĻŋāĻ¤ āĻšā§ā§āĻā§
ā§§ā§¯ā§¯ā§¯
āĻā§ā§āĻŦāĻ¸āĻžāĻāĻ
āĻāĻ°ā§āĻŽāĻāĻžāĻ°ā§
ā§§ā§Šā§Ē
